Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
5.42M
-
Shares change
-
-28.5K
-
Total reported value, excl. options
-
$38.3M
-
Value change
-
-$194K
-
Number of buys
-
8
-
Number of sells
-
-15
-
Price
-
$7.06
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q3 2017
33 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q3 2017.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.42M shares
of 15M outstanding shares and own 36.22% of the company stock.
Largest 10 shareholders include Stonepine Capital Management, LLC (1.27M shares), ARIEL INVESTMENTS, LLC (887K shares), DIMENSIONAL FUND ADVISORS LP (872K shares), BlackRock Inc. (394K shares), RENAISSANCE TECHNOLOGIES LLC (316K shares), VANGUARD GROUP INC (303K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (284K shares), JW Asset Management, LLC (264K shares), NEW YORK STATE COMMON RETIREMENT FUND (250K shares), and ACADIAN ASSET MANAGEMENT LLC (128K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.